Trupanion (NASDAQ:TRUP) Stock Rating Upgraded by Bank of America

Trupanion (NASDAQ:TRUP - Get Free Report) was upgraded by investment analysts at Bank of America from a "neutral" rating to a "buy" rating in a report issued on Thursday, MarketBeat.com reports. The firm presently has a $49.00 price target on the financial services provider's stock, up from their prior price target of $35.00. Bank of America's target price indicates a potential upside of 49.30% from the stock's current price.

A number of other research firms also recently weighed in on TRUP. Piper Sandler decreased their price target on shares of Trupanion from $28.00 to $22.00 and set a "neutral" rating for the company in a research report on Friday, May 3rd. Evercore ISI cut their target price on shares of Trupanion from $35.00 to $31.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 20th. Canaccord Genuity Group decreased their price target on Trupanion from $40.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, May 3rd. Finally, Stifel Nicolaus increased their target price on Trupanion from $25.00 to $28.00 and gave the stock a "hold" rating in a report on Friday, February 16th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $32.80.

Trupanion Stock Up 15.8 %

TRUP stock traded up $4.49 during trading on Thursday, reaching $32.82. The stock had a trading volume of 2,046,744 shares, compared to its average volume of 771,241. The firm has a fifty day moving average price of $25.48 and a 200 day moving average price of $26.93. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $1.38 billion, a P/E ratio of -52.36 and a beta of 1.76. Trupanion has a 1-year low of $18.45 and a 1-year high of $36.66.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.02. Trupanion had a negative return on equity of 9.03% and a negative net margin of 2.31%. The firm had revenue of $306.12 million during the quarter, compared to the consensus estimate of $300.51 million. During the same quarter in the prior year, the business posted ($0.60) earnings per share. Trupanion's revenue for the quarter was up 19.4% on a year-over-year basis. On average, equities analysts anticipate that Trupanion will post -0.48 earnings per share for the current year.

Insider Activity at Trupanion

In related news, SVP Emily Dreyer sold 3,125 shares of the firm's stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $25.34, for a total value of $79,187.50. Following the sale, the senior vice president now owns 19,830 shares of the company's stock, valued at approximately $502,492.20. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, SVP Emily Dreyer sold 3,125 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $25.34, for a total value of $79,187.50. Following the sale, the senior vice president now owns 19,830 shares of the company's stock, valued at approximately $502,492.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Darryl Rawlings bought 20,700 shares of Trupanion stock in a transaction on Tuesday, May 7th. The shares were purchased at an average cost of $24.14 per share, with a total value of $499,698.00. Following the completion of the purchase, the chief executive officer now directly owns 614,842 shares in the company, valued at $14,842,285.88. The disclosure for this purchase can be found here. Insiders own 5.81% of the company's stock.

Institutional Trading of Trupanion

Several large investors have recently added to or reduced their stakes in the business. Bayesian Capital Management LP acquired a new position in Trupanion during the 1st quarter worth $253,000. Price T Rowe Associates Inc. MD lifted its holdings in Trupanion by 14.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,325 shares of the financial services provider's stock worth $313,000 after purchasing an additional 1,441 shares during the period. CANADA LIFE ASSURANCE Co grew its position in Trupanion by 2.0% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider's stock valued at $1,188,000 after buying an additional 830 shares in the last quarter. Vanguard Group Inc. increased its stake in Trupanion by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider's stock valued at $101,433,000 after buying an additional 32,485 shares during the period. Finally, State Board of Administration of Florida Retirement System raised its position in shares of Trupanion by 12.6% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 12,726 shares of the financial services provider's stock worth $351,000 after buying an additional 1,420 shares in the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.